Navigation Links
Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology

Neurological disability typically accumulates over time and includes muscle weakness and spasticity, balance and coordination problems, as well as memory impairment and depression. Other symptoms include numbness, pain, slurred speech and blurred vision. Many patients experience fatigue and problems with bladder, bowel or sexual function.

While MS has traditionally been considered a T-cell mediated disease, recent research suggests that B-cells may play multiple roles in the initiation and development of MS.

Rituxan Safety Profile in Rheumatoid Arthritis and Oncology
The safety profile of Rituxan in rheumatoid arthritis and non-Hodgkin's lymphoma (NHL) has been evaluated through a number of clinical trials.

The most common adverse events observed in rheumatoid arthritis (RA) patients treated with Rituxan in clinical studies of up to 24 weeks were infection and infusion reactions. Among non-Hodgkin's lymphoma patients treated with Rituxan in clinical studies, the most common adverse events were infusion reactions and cytopenias (low blood cell counts).

The majority of patients experiencing an infusion-related reaction do so during their first Rituxan infusion. These symptoms include but are not limited to: flu-like illness, fever, chills/rigors, nausea, urticaria, headache, bronchospasm, angioedema, hypotension and hypoxia. These symptoms vary in severity and generally are reversible.

Severe infusion reactions have been reported in patients treated with Rituxan, some with fatal outcomes. These severe reactions typically occur during the first infusion. The most severe manifestations and sequelae include hypoxia, pulmonary infiltrates, acute respiratory distress syndrome, myocardial infarction, ventricular fibrillation and cardiogenic shock.

Acute renal failure requiring dialysis with instances of fatal outcome has been reported in the setting of tumor lysis syndrome following treatment with Rituxan in patients wi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:10/31/2014)... , Oct. 30, 2014 Electronic ... electronic transmission of prescription related information between ... system allows a physician and nurse practitioner ... a medication error occurs during pharmacy operations. ... applications. It provides complete medical lists, conducts ...
(Date:10/31/2014)... Oct. 31, 2014 Though therapies are in ... expected to show an annual increase of 16.2% over ... nearly $1 billion, according to Kalorama Information,s report, ... stem cell therapeutics that have gained or are expected ... "As drug developers tackle ever more complicated conditions, stem ...
(Date:10/30/2014)... Oct. 30, 2014 /CNW/ - Atlantic Canadians will save ... between Canada,s provinces and territories ... President of the Canadian Generic Pharmaceutical Association (CGPA), said ... while speaking at the Atlantic Summit on Healthcare and ... which is being hosted by the Public Policy Forum ...
Breaking Medicine Technology:E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Report: Stem Cell Technologies Market Growing 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3
... 2011 Nektar Therapeutics (Nasdaq: NKTR ) today reported ... Cash, cash equivalents, and investments at September 30, ... 31, 2010. Revenue for the third quarter of ... in the third quarter of 2010 primarily as a result of ...
... NEW YORK, Nov. 2, 2011 JDRF and The Leona ... largest non-government funders of type 1 diabetes (T1D) programs, announced ... a new level of cooperation between the organizations. The goal ... and development to deliver better treatments, devices, and diagnostics for ...
Cached Medicine Technology:Nektar Therapeutics Reports Third Quarter 2011 Financial Results 2Nektar Therapeutics Reports Third Quarter 2011 Financial Results 3Nektar Therapeutics Reports Third Quarter 2011 Financial Results 4Nektar Therapeutics Reports Third Quarter 2011 Financial Results 5Nektar Therapeutics Reports Third Quarter 2011 Financial Results 6Nektar Therapeutics Reports Third Quarter 2011 Financial Results 7Nektar Therapeutics Reports Third Quarter 2011 Financial Results 8JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development 2JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development 3JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development 4
(Date:10/31/2014)... 31, 2014 The Memory Healer review published ... Alexander Lynch, whose father suffered from Alzheimer's disease. , ... caused by his father's disease. His father pointed a gun ... crucial moment when the author of this method understood that ... , The Memory Healer program is based on years of ...
(Date:10/31/2014)... 31, 2014 Monica Williams-Murphy MD ... all too well the chaos that can occur for ... “The vast majority of Americans who come into the ... are completely unprepared for the moment and so are ... can serve as a catalyst for a family to ...
(Date:10/31/2014)... Summit, Missouri (PRWEB) October 31, 2014 ... the country about families narrowly escaping carbon monoxide poisoning ... season) looms just weeks away, one family-owned, Missouri-based heating ... straightforward approach to making sure families start the home ... are safe and secure. , Beginning Nov. 1, ...
(Date:10/31/2014)... UT (PRWEB) October 31, 2014 ... new Activz Silver line offering natural silver ... wipes. For over a century, silver has been used ... in Activz Silver products is the most advanced version ... has a unique chemical structure that supports the existing ...
(Date:10/31/2014)... Surgery for low back pain caused by spinal stenosis ... live, a new report says. "Nearly 80 percent ... point in their lives, and about 30 million people ... problem," co-author Brook Martin, of the Dartmouth Institute of ... news release. In spinal stenosis, thickening of tissue ...
Breaking Medicine News(10 mins):Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Spinal Surgery Varies by Region in U.S.: Study 2
... Acuo Technologies(R), developers of the market leading high-performance ... tools and services, announces another year of record ... 91% growth over the previous year in sales ... while adding 72 additional implementations of the DICOM ...
... chain honored for accomplishments , ... Dallas (Vocus) March 3, 2009 -- ... Alliance of Greater Cincinnati, was recently announced 2008 Contracting Professional of the ... ,Described as a pioneer in healthcare for more than three decades, Robb ...
... InfuSystem Holdings, Inc. (OTC Bulletin Board: INHI; ... pumps and associated clinical services, today announced financial results ... ended December 31, 2008.Mr. Steve Watkins, chief executive officer, ... in revenue to $9.1 million for the fourth quarter ...
... Promotions and Educating Consumers of the Importance of Eye ... remind families that having healthy eyes and seeing clearly ... Optical announced today the launch of its annual "Family ... throughout the month of March, Sears Optical is encouraging ...
... CorNova, Inc. today announced the addition of Andrew ... The addition increases board membership to 4.(Logo: ... partner of the Medical Solutions Fund of Siemens ... AG. Prior to joining Siemens Venture Capital, ...
... Genoptix, Inc. (Nasdaq: GXDX ), a ... in the Barclays Capital Global Healthcare Conference at the ... 10 - 11, 2009. Dr. Tina Nova, President ... on Tuesday, March 10, 2009 beginning at approximately 2:30pm ...
Cached Medicine News:Health News:Acuo Technologies(R) Announces Another Record Sales and Implementation Growth 2Health News:The Health Alliance's Dennis Robb Announced Contracting Professional of the Year by The Journal of Healthcare Contracting 2Health News:The Health Alliance's Dennis Robb Announced Contracting Professional of the Year by The Journal of Healthcare Contracting 3Health News:The Health Alliance's Dennis Robb Announced Contracting Professional of the Year by The Journal of Healthcare Contracting 4Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 2Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 3Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 4Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 5Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 6Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 7Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 8Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 9Health News:InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008 10Health News:Sears Optical Celebrates Annual Family Eye Health Month 2Health News:Sears Optical Celebrates Annual Family Eye Health Month 3Health News:CorNova Announces Addition of Andrew T. Jay, D.M.D., M.B.A., to its Board of Directors 2Health News:Genoptix Announces Participation at Barclays Capital Global Healthcare Conference 2
... Wash both 96- and 384-well ... Auto Strip Washer. As a self ... allows for full control of precise ... of a simple squeeze bottle to ...
The EL401 Manual Plate/Strip Washer accommodates all 96-well microplates and microwell strips. The unique alignment mechanism allows quick and accurate positioning of the 8- or 12-channel manifold ab...
... is especially designed for the atraumatic removal ... sleek design of this probe minimizes the ... Due to its 24K gold plating, the ... foreign body incarceration. The magnetic probe is ...
... Designed for flexible continuous monitoring, the ... for adult, pediatric and neonatal patient care. ... Multi-Measurement Server that includes a basic set ... pressure or temperature. Optional Multi-Measurement Server extensions ...
Medicine Products: